TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

By S. Hussain, J. Schwank, F. Staib, Xw Wang, CC Harris. Oncogene, 2007

598 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/f5afd163ceb4e408a8c9562802ef0cde671b3cd2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Li‐Weber
2. S. Caldwell
3. G. Baffy
4. E. Brunt

In Oncology

1. Magali Olivier
2. M. Hollstein
3. Pierre Hainaut
4. M. Li‐Weber
5. Varda Rotter

Citations in the corpus

• New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. (2009, methodology): “5 lg/ml [164] Env and CXCR4/CCR5 fusion with IC50 of 4 lM [16]”
• TP53 mutations in human cancers: origins, consequences, and clinical use. (2010, background): “2003), and exposure to dietary aflatoxinB1 and G to T transversions at the third base of codon 249 (AGG to AGT) in tumors from HBV carriers (Hussain et al. 2007).”
• Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. (2012, background): “In Sub-Saharan Africa, dietary exposure to aflatoxin may synergize with the carcinogenic effects of chronic hepatitis B infection [47].”